Could a 9-Week online course ease the wait for a kidney transplant?
NCT ID NCT06332469
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This study tests whether a guided internet-based education and support program can help people with severe kidney failure who are waiting for a kidney transplant. The program includes 9 weekly modules covering kidney disease, treatment, self-care, and coping strategies. Researchers will measure if the program is practical and acceptable, and whether it improves patients' knowledge, self-care, and mental health. The study involves 30 adults on the transplant waiting list in Sweden, with some receiving the program immediately and others after a wait.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A guided internet-based education and support program with 9 modules over 9 weeks, covering kidney disease, treatment, self-care, and behavioral support.
- What this could lead to
- If it works, this program could give people on the kidney transplant waiting list a practical way to learn about their condition, feel more in control, and improve their mental well-being while they wait.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply to everyone. The program requires a time commitment of 3-4 hours per week, and some people may not find it helpful or engaging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
May 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years and older * severe renal failure and accepted on waiting list for kidney transplant with deceased donor in Sweden since at least 6 months Exclusion Criteria: * Not considering themselves able to spend 3-4 hours/week to work in the program * Another illness that permanently renders kidney transplantation impossible
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Linköping University
Norrköping, Sweden
-
Linköping University,
Norrköping, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of sodium zirconium cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD)
- Hidden kidney damage may lurk in rheumatoid arthritis patients
- Can we predict who will progress quickly to kidney failure?
- Can a chatbot help african american kidney donors decide with confidence?
- Can a Patient's own kidney cells slow kidney disease?
- Digital tool aims to empower kidney patients to take control